Inhibitory Activities of Dimeric Ellagitannins Isolated from Cornus alba on Benign Prostatic Hypertrophyopen access
- Authors
- Park, Dong-Hui; Park, Kwan-Hee; Yin, Jun; Kim, Min-Ji; Yoon, Seong-Eun; Lee, Sun-Ho; Heo, Jun-Hyeok; Chung, Hyun-Joo; Kim, Jin-Wook; Kim, Kyung-Mi; Lee, Min-Won
- Issue Date
- Jun-2021
- Publisher
- MDPI
- Keywords
- dimeric ellagitannin; Cornus alba; benign prostatic hypertrophy; BPH
- Citation
- MOLECULES, v.26, no.11
- Journal Title
- MOLECULES
- Volume
- 26
- Number
- 11
- URI
- https://scholarworks.bwise.kr/cau/handle/2019.sw.cau/50558
- DOI
- 10.3390/molecules26113446
- ISSN
- 1420-3049
1420-3049
- Abstract
- Benign prostatic hypertrophy (BPH) is an intractable chronic inflammatory disease. We studied the efficacy of two ellagitannins, namely camptothin B (1) and cornusiin A (2) that were isolated from Cornus alba (CA) for the treatment of BPH, which is a common health issue in older men. The ellagitannins (1 and 2) were evaluated on its inhibitory activities of the enzyme 5 alpha-reductase and tumor necrosis factor (TNF)-alpha, its interleukin (IL)-1 beta, IL-6, and IL-8 production, and its anti-proliferation and apoptosis induction in prostate cells that show hypertrophy (RWPE-1 cell). In inhibition of 5 alpha-reductase, the ellagitannins (1 and 2) showed potential effects, compared to the positive control, finasteride. In the case of IL-1 beta, IL-6, IL-8, and TNF-alpha, 1 and 2 showed good inhibitory effects as compared to the control group treated with LPS. The ellagitannins (1 and 2) were also shown to inhibit proliferation of, and induce apoptosis in, the RWPE-1 cell. These results suggest that the ellagitannins (1 and 2) may be good candidates for the treatment of BPH.
- Files in This Item
-
- Appears in
Collections - College of Pharmacy > School of Pharmacy > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.